NCT01749878View on ClinicalTrials.gov

Study to Assess the Safety and Tolerability of Single Doses of REGN1500

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Hypertriglyceridemia
Interventions
DRUG

REGN1500

DRUG

placebo

Trial Locations (2)

Unknown

Philadelphia

Dallas

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01749878 - Study to Assess the Safety and Tolerability of Single Doses of REGN1500 | Biotech Hunter | Biotech Hunter